Screening for prostate cancer: an update.

Screening for prostate cancer: an update.

The introduction of total prostate-specific antigen (tPSA) testing in serum has revolutionized the detection and management of men with prostate cancer. This review will highlight some of the exciting new developments in the field of prostate cancer screening in general and from our SPORE research p...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Shariat, S, Scardino, P, Lilja, H
Materialtyp:	Journal article
Språk:	English
Publicerad:	2008

Liknande verk

Five genetic variants associated with prostate cancer.
av: Vickers, A, et al.
Publicerad: (2008)

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
av: Vickers, A, et al.
Publicerad: (2010)

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.
av: Vickers, A, et al.
Publicerad: (2010)

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.
av: Carlsson, S, et al.
Publicerad: (2012)

Screening for prostate cancer.
av: Carlsson, S, et al.
Publicerad: (2012)

Screening for prostate cancer: an update.
av: Bryant, R, et al.
Publicerad: (2008)

Screening for prostate cancer: To the editor
av: Carlsson, S, et al.
Publicerad: (2012)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden.
av: Vickers, A, et al.
Publicerad: (2008)

Prostate cancer: estimating the benefits of PSA screening.
av: Vickers, A, et al.
Publicerad: (2009)

The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
av: Vickers, A, et al.
Publicerad: (2007)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.
av: Gupta, A, et al.
Publicerad: (2010)

Urological cancer: Time for another rethink on prostate cancer screening.
av: Vickers, A, et al.
Publicerad: (2012)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
av: Bangma, C, et al.
Publicerad: (2010)

Screening for prostate cancer: early detection or overdetection?
av: Vickers, A, et al.
Publicerad: (2012)

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.
av: Vickers, A, et al.
Publicerad: (2010)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
av: Scardino Peter T, et al.
Publicerad: (2008-07-01)

Lead time associated with screening for prostate cancer.
av: Törnblom, M, et al.
Publicerad: (2004)

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.
av: Vickers, A, et al.
Publicerad: (2011)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
av: Vickers, A, et al.
Publicerad: (2010)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
av: Vickers, A, et al.
Publicerad: (2010)

Tumor markers in prostate cancer I: blood-based markers.
av: Shariat, S, et al.
Publicerad: (2011)

Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
av: Stephenson, A, et al.
Publicerad: (2006)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
av: Steuber, T, et al.
Publicerad: (2007)

Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer.
av: Lilja, H, et al.
Publicerad: (2007)

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
av: Zackrisson, B, et al.
Publicerad: (2003)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
av: Hugosson, J, et al.
Publicerad: (2003)

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
av: Vickers, A, et al.
Publicerad: (2010)

Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial.
av: Aus, G, et al.
Publicerad: (2007)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
av: Becker, C, et al.
Publicerad: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
av: Becker, C, et al.
Publicerad: (2003)

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
av: Hugosson, J, et al.
Publicerad: (2003)

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
av: Lilja, H, et al.
Publicerad: (2011)

Circulating biomarkers for prostate cancer.
av: Steuber, T, et al.
Publicerad: (2007)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
av: Steuber, T, et al.
Publicerad: (2007)

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.
av: Bruun, L, et al.
Publicerad: (2005)

Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.
av: Bergdahl, A, et al.
Publicerad: (2009)

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
av: Ulmert, D, et al.
Publicerad: (2008)

Erratum: PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section (International Journal of Cancer (2007) 120, (170-174))
av: Khatami, A, et al.
Publicerad: (2007)

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
av: Roobol, M, et al.
Publicerad: (2009)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
av: Klein, R, et al.
Publicerad: (2012)